VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $35,825 | -100.0% | 1,250 | -94.8% | 0.01% | -91.5% |
| Q1 2021 | $776,750,000 | -41.7% | 23,900 | -35.4% | 0.13% | -48.4% |
| Q4 2020 | $1,332,740,000 | +43.6% | 37,000 | +56.1% | 0.25% | +32.3% |
| Q3 2020 | $928,092,000 | -47.4% | 23,700 | -50.7% | 0.19% | -42.7% |
| Q2 2020 | $1,764,308,000 | +21.2% | 48,100 | -23.9% | 0.33% | -23.8% |
| Q1 2020 | $1,456,128,000 | +55224.0% | 63,200 | -29.7% | 0.43% | +4.1% |
| Q4 2019 | $2,632,000 | +103.6% | 89,900 | +85.7% | 0.42% | +199.3% |
| Q3 2019 | $1,293,000 | -69.5% | 48,400 | -70.8% | 0.14% | -74.8% |
| Q2 2019 | $4,238,000 | +249.4% | 165,800 | +206.5% | 0.55% | +299.3% |
| Q1 2019 | $1,213,000 | -33.9% | 54,100 | -32.3% | 0.14% | -22.5% |
| Q3 2017 | $1,835,000 | +0.3% | 79,900 | +15.5% | 0.18% | -12.3% |
| Q3 2016 | $1,829,000 | +11.5% | 69,200 | +16.9% | 0.20% | +24.5% |
| Q2 2016 | $1,640,000 | – | 59,200 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |